COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2394-2746

Online ISSN:-2394-2754


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 546

Emailed: 0

PDF Downloaded: 180

Indian Journal of Obstetrics and Gynecology Research

Study of efficacy of misoprostol in reduced dose via vaginal route in first trimester abortion

Full Text PDF Share on Facebook Share on Twitter

Author Details : Alpana Bansal, Meena Saxena, Mukesh Bansal

Volume : 4, Issue : 4, Year : 2017

Article Page : 392-394

Suggest article by email



Objective: The present study is prospective study of Misoprostol in reduced dose via vaginal route to minimise side effect in first trimester abortion.
Materials and Method: 200 mg of mifepristone given orally followed by 400 mg misoprostol intra virginally after 24 hours, and after 24 hrs of vaginal misoprostol 400 mg of misoprostol was given orally.
Result: The 140 women were analyzed, 134 of these women had complete abortion after completion of the treatment regimen, and success rate of 95.7% was achieved.
Conclusion: Use of400 mg misoprostol vaginally after 24 hours of oral mifepristone, have less side effect and effective result for medical abortion in first trimester abortion.

Keywords: Misoprostole, Mifepristone, 1st trimester abortion,


How to cite : Bansal A, Saxena M, Bansal M, Study of efficacy of misoprostol in reduced dose via vaginal route in first trimester abortion. Indian J Obstet Gynecol Res 2017;4(4):392-394

Copyright © 2017 by author(s) and Indian J Obstet Gynecol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (